Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis

• Published in: Frontiers in neurology Vol. 13; p. 764690
• Main Authors: O'Grady, Kristin P, Satish, Sanjana, Owen, Quinn R, Box, Bailey A, Bagnato, Francesca, Combes, Anna J E, Cook, Sarah R, Westervelt, Holly James, Feiler, Haley R, Lawless, Richard D, Sarma, Asha, Malone, Shekinah D, Ndolo, Josephine M, Yoon, Keejin, Dortch, Richard D, Rogers, Baxter P, Smith, Seth A
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 25-02-2022
• Subjects: apparent exchange-dependent relaxation (AREX); chemical exchange saturation transfer (CEST); glutamate; metabolic imaging; multiple sclerosis; Neurology; ultrahigh field; cognition; ultrahigh field; multiple sclerosis; chemical exchange saturation transfer (CEST); metabolic imaging; apparent exchange-dependent relaxation (AREX); glutamate
• ISSN: 1664-2295; 1664-2295
• DOI: 10.3389/fneur.2022.764690

Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) can probe tissue biochemistry
with high resolution and sensitivity without requiring exogenous contrast agents. Applying CEST MRI at ultrahigh field provides advantages of increasing spectral resolution and improving sensitivity to metabolites with faster proton exchange rates such as glutamate, a critical neurotransmitter in the brain. Prior magnetic resonance spectroscopy and CEST MRI studies have revealed altered regulation of glutamate in patients with multiple sclerosis (MS). While CEST imaging facilitates new strategies for investigating the pathology underlying this complex and heterogeneous neurological disease, CEST signals are contaminated or diluted by concurrent effects (e.g., semi-solid magnetization transfer (MT) and direct water saturation) and are scaled by the T
relaxation time of the free water pool which may also be altered in the context of disease. In this study of 20 relapsing-remitting MS patients and age- and sex-matched healthy volunteers, glutamate-weighted CEST data were acquired at 7.0 T. A Lorentzian fitting procedure was used to remove the asymmetric MT contribution from CEST z-spectra, and the apparent exchange-dependent relaxation (AREX) correction was applied using an R
map derived from an inversion recovery sequence to further isolate glutamate-weighted CEST signals from concurrent effects. Associations between AREX and cognitive function were examined using the Minimal Assessment of Cognitive Function in MS battery. After isolating CEST effects from MT, direct water saturation, and T
effects, glutamate-weighted AREX contrast remained higher in gray matter than in white matter, though the difference between these tissues decreased. Glutamate-weighted AREX in normal-appearing gray and white matter in MS patients did not differ from healthy gray and white matter but was significantly elevated in white matter lesions. AREX in some cortical regions and in white matter lesions correlated with disability and measures of cognitive function in MS patients. However, further studies with larger sample sizes are needed to confirm these relationships due to potential confounding effects. The application of MT and AREX corrections in this study demonstrates the importance of isolating CEST signals for more specific characterization of the contribution of metabolic changes to tissue pathology and symptoms in MS.